Transgender women on oral HIV pre‐exposure prophylaxis have significantly lower tenofovir and emtricitabine concentrations when also taking oestrogen when compared to cisgender men

Decreased tenofovir diphosphate concentrations in a transgender female cohort: Implications for HIV pre-exposure prophylaxis (PrEP)

(2019) Mackenzie L Cottrell et al.   CLINICAL INFECTIOUS DISEASES

Drug‐drug interactions between feminizing hormone therapy and pre‐exposure prophylaxis among transgender women: the iFACT study

(2019) Akarin Hiransuthikul et al.   Journal of the International AIDS Society

Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral pre-exposure prophylaxis

(2018) Maria Pyra et al.   AIDS

Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

(2017) Jean-Michel Molina et al.   Lancet HIV

Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine After Directly Observed Dosing in Healthy Volunteers to Establish Adherence Benchmarks (HPTN 066)

(2016) Craig W. Hendrix et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Testosterone downregulates angiotensin II type-2 receptor via androgen receptor-mediated ERK1/2 MAP kinase pathway in rat aorta

(2016) J. S. Mishra et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Simultaneous Evaluation of Safety, Acceptability, Pericoital Kinetics, and Ex Vivo Pharmacodynamics Comparing Four Rectal Microbicide Vehicle Candidates

(2015) Francisco Leyva et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial

(2015) Madeline B Deutsch et al.   Lancet HIV

Sex Hormones Regulate Tenofovir-Diphosphate in Female Reproductive Tract Cells in Culture

(2014) Zheng Shen et al.   PLoS One

Adding value to antiretroviral proficiency testing

(2014) Robin DiFrancesco et al.   Bioanalysis

Single Dose Pharmacokinetics of Oral Tenofovir in Plasma, Peripheral Blood Mononuclear Cells, Colonic Tissue, and Vaginal Tissue

(2013) Nicolette A. Louissaint et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments

(2013) Craig W. Hendrix et al.   PLoS One

Worldwide burden of HIV in transgender women: a systematic review and meta-analysis

(2012) Stefan D Baral et al.   LANCET INFECTIOUS DISEASES

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

(2012) P. L. Anderson et al.   Science Translational Medicine

Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC–MS/MS detection

(2011) Lane R. Bushman et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Sex specific response of cultured human bone cells to ERα and ERβ specific agonists by modulation of cell proliferation and creatine kinase specific activity

(2011) Dalia Somjen et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel

(2011) Marla J. Keller et al.   PLoS One

Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

(2010) Robert M. Grant et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function

(2008) Sofia B. Ahmed et al.   KIDNEY INTERNATIONAL